Issue
NET-1 promotes invasion, adhesion and growth of hepatocellular carcinoma by regulating the expression of BAX, caspase 3, caspase 8 and BCL2
Corresponding Author(s) : Xiangjun Sun
Cellular and Molecular Biology,
Vol. 64 No. 12: Issue 12
Abstract
Dysregulation of neuroepithelial transforming gene-1 (NET-1) has been shown in hepatocellular carcinoma (HCC) patients. We aimed to evaluate the influence of NET-1 on HCC invasion, adhesion and growth. In vitro cellular functional assays including invasion and adhesion were performed to evaluate the effects of knockdown and overexpression of NET-1. HCC cells were transplanted into nude mice, and tumor growth was assessed. BAX, caspase 3, caspase 8 and BCL2 protein levels were detected by western blot. After transfection with NET-1 siRNA, NET-1 positive ratio in HCC cells significantly decreased. Cell invasion and adhesion assay showed that knockdown of NET-1 reduced the invasion and adhesion ability of HCC cells, whereas overexpression of NET-1 increased the ability. The evaluation of tumor growth revealed that NET-1 knockdown significantly decreased tumor volume and weight, while NET-1 overexpression promoted tumor growth in nude mice. Western blot showed that NET-1 knockdown increased BAX, caspase 3 and caspase 8 expression but decreased BCL2 expression, whereas NET-1 overexpression significantly down-regulated BAX, caspase 3 and caspase 8 expression but increased BCL2 expression. Our data suggest that NET-1 promotes HCC invasion, adhesion and growth by regulating BAX, caspase 3, caspase 8 and BCL2 expression.
Keywords
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
- Hartke J, Johnson M, Ghabril M. The diagnosis and treatment of hepatocellular carcinoma. Semin Diagn Pathol. 2017;34(2):153-159.
- Desai JR, Ochoa S, Prins PA, He AR. Systemic therapy for advanced hepatocellular carcinoma: an update. J Gastrointest Oncol. 2017;8(2):243-255.
- Bupathi M, Kaseb A, Janku F. Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives. Onco Targets Ther. 2014;7:1927-32.
- Wang PL, Liu B, Xia Y, Pan CF, Ma T, Chen YJ. Long non-coding RNA-Low Expression in Tumor inhibits the invasion and metastasis of esophageal squamous cell carcinoma by regulating p53 expression. Mol Med Rep. 2016;13(4):3074-82.
- Li JP, Liu Y, Yin YH. ARHGAP1 overexpression inhibits proliferation, migration and invasion of C-33A and SiHa cell lines. Onco Targets Ther. 2017;10:691-701.
- Murray D, Horgan G, Macmathuna P, Doran P. NET1-mediated RhoA activation facilitates lysophosphatidic acid-induced cell migration and invasion in gastric cancer. Br J Cancer. 2008;99(8):1322-9.
- Ye K, Wang Z, Zhang G, Liang S. Prognostic significance of neuroepithelial transforming protein 1 in hepatocellular carcinoma. J Invest Surg. 2010;23(3):163-9.
- Fang L, Zhu J, Ma Y, Hong C, Xiao S, Jin L. Neuroepithelial transforming gene 1 functions as a potential prognostic marker for patients with non-small cell lung cancer. Mol Med Rep. 2015;12(5):7439-46.
- Shen SQ, Li K, Zhu N, Nakao A. Expression and clinical significance of NET-1
- and PCNA in hepatocellular carcinoma. Med Oncol. 2008;25(3):341-5.
- Wang GL, Chen L, Wei YZ, et al. The effect of NET-1 on the proliferation, migration and endocytosis of the SMMC-7721 HCC cell line. Oncol Rep. 2012;27(6):1944-52.
- Han X, Cheng W, Jing H, Zhang JW, Tang LL. Neuroepithelial transforming protein 1 short interfering RNA-mediated gene silencing with microbubble and ultrasound exposure inhibits the proliferation of hepatic carcinoma cells in vitro. J Ultrasound Med. 2012;31(6):853-61.
- Llovet JM, Zucman-Rossi J, Pikarsky E, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2016;2:16018.
- Boyle DA. Hepatocellular Carcinoma: Implications for Asian-Pacific Oncology Nurses. Asia Pac J Oncol Nurs. 2017;4(2):98-103.
- Xu J, Stolk JA, Zhang X, et al. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer
- Res. 2000;60(6):1677-82.
- He S, Wei YZ, Wang GL, et al. Study of RNA Interference Targeting NET-1 Combination with Sorafenib for Hepatocellular Carcinoma Therapy In Vitro and In Vivo. Gastroenterol Res Pract. 2013;2013:685150.
- Pirocanac EC, Nassirpour R, Yang M, et al.Bax-induction gene therapy of pancreatic cancer. J Surg Res. 2002;106(2):346-51.
- Guo XZ, Shao XD, Liu MP, et al. Effect of bax, bcl-2 and bcl-xL on regulating apoptosis in tissues of normal liver and hepatocellular carcinoma. World J
- Gastroenterol. 2002;8(6):1059-62.
- Liu YK, Chen KH, Leu YL, et al. Ethanol extracts of Cinnamomum kanehirai Hayata leaves induce apoptosis in human hepatoma cell through caspase-3 cascade. Onco Targets Ther. 2014;8:99-109.
- Sun BH, Zhang J, Wang BJ, et al. Analysis of in vivo patterns of caspase 3 gene expression in primary hepatocellular carcinoma and its relationship to p21(WAF1) expression and hepatic apoptosis. World J Gastroenterol. 2000;6(3):356-360.
- Tummers B, Green DR. Caspase-8: regulating life and death. Immunol Rev.
- ;277(1):76-89.
- Soung YH, Lee JW, Kim SY, et al. Caspase-8 gene is frequently inactivated by the frameshift somatic mutation 1225_1226delTG in hepatocellular carcinomas. Oncogene. 2005;24(1):141-7.
- Youle RJ, Strasser A. The BCL-2 protein family:opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 2008;9(1):47-59.
- Chun E, Lee KY. Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells. Biochem Biophys Res Commun. 2004;315(3):771-9.
References
Hartke J, Johnson M, Ghabril M. The diagnosis and treatment of hepatocellular carcinoma. Semin Diagn Pathol. 2017;34(2):153-159.
Desai JR, Ochoa S, Prins PA, He AR. Systemic therapy for advanced hepatocellular carcinoma: an update. J Gastrointest Oncol. 2017;8(2):243-255.
Bupathi M, Kaseb A, Janku F. Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives. Onco Targets Ther. 2014;7:1927-32.
Wang PL, Liu B, Xia Y, Pan CF, Ma T, Chen YJ. Long non-coding RNA-Low Expression in Tumor inhibits the invasion and metastasis of esophageal squamous cell carcinoma by regulating p53 expression. Mol Med Rep. 2016;13(4):3074-82.
Li JP, Liu Y, Yin YH. ARHGAP1 overexpression inhibits proliferation, migration and invasion of C-33A and SiHa cell lines. Onco Targets Ther. 2017;10:691-701.
Murray D, Horgan G, Macmathuna P, Doran P. NET1-mediated RhoA activation facilitates lysophosphatidic acid-induced cell migration and invasion in gastric cancer. Br J Cancer. 2008;99(8):1322-9.
Ye K, Wang Z, Zhang G, Liang S. Prognostic significance of neuroepithelial transforming protein 1 in hepatocellular carcinoma. J Invest Surg. 2010;23(3):163-9.
Fang L, Zhu J, Ma Y, Hong C, Xiao S, Jin L. Neuroepithelial transforming gene 1 functions as a potential prognostic marker for patients with non-small cell lung cancer. Mol Med Rep. 2015;12(5):7439-46.
Shen SQ, Li K, Zhu N, Nakao A. Expression and clinical significance of NET-1
and PCNA in hepatocellular carcinoma. Med Oncol. 2008;25(3):341-5.
Wang GL, Chen L, Wei YZ, et al. The effect of NET-1 on the proliferation, migration and endocytosis of the SMMC-7721 HCC cell line. Oncol Rep. 2012;27(6):1944-52.
Han X, Cheng W, Jing H, Zhang JW, Tang LL. Neuroepithelial transforming protein 1 short interfering RNA-mediated gene silencing with microbubble and ultrasound exposure inhibits the proliferation of hepatic carcinoma cells in vitro. J Ultrasound Med. 2012;31(6):853-61.
Llovet JM, Zucman-Rossi J, Pikarsky E, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2016;2:16018.
Boyle DA. Hepatocellular Carcinoma: Implications for Asian-Pacific Oncology Nurses. Asia Pac J Oncol Nurs. 2017;4(2):98-103.
Xu J, Stolk JA, Zhang X, et al. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer
Res. 2000;60(6):1677-82.
He S, Wei YZ, Wang GL, et al. Study of RNA Interference Targeting NET-1 Combination with Sorafenib for Hepatocellular Carcinoma Therapy In Vitro and In Vivo. Gastroenterol Res Pract. 2013;2013:685150.
Pirocanac EC, Nassirpour R, Yang M, et al.Bax-induction gene therapy of pancreatic cancer. J Surg Res. 2002;106(2):346-51.
Guo XZ, Shao XD, Liu MP, et al. Effect of bax, bcl-2 and bcl-xL on regulating apoptosis in tissues of normal liver and hepatocellular carcinoma. World J
Gastroenterol. 2002;8(6):1059-62.
Liu YK, Chen KH, Leu YL, et al. Ethanol extracts of Cinnamomum kanehirai Hayata leaves induce apoptosis in human hepatoma cell through caspase-3 cascade. Onco Targets Ther. 2014;8:99-109.
Sun BH, Zhang J, Wang BJ, et al. Analysis of in vivo patterns of caspase 3 gene expression in primary hepatocellular carcinoma and its relationship to p21(WAF1) expression and hepatic apoptosis. World J Gastroenterol. 2000;6(3):356-360.
Tummers B, Green DR. Caspase-8: regulating life and death. Immunol Rev.
;277(1):76-89.
Soung YH, Lee JW, Kim SY, et al. Caspase-8 gene is frequently inactivated by the frameshift somatic mutation 1225_1226delTG in hepatocellular carcinomas. Oncogene. 2005;24(1):141-7.
Youle RJ, Strasser A. The BCL-2 protein family:opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 2008;9(1):47-59.
Chun E, Lee KY. Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells. Biochem Biophys Res Commun. 2004;315(3):771-9.